JP2024541089A5 - - Google Patents
Info
- Publication number
- JP2024541089A5 JP2024541089A5 JP2024529509A JP2024529509A JP2024541089A5 JP 2024541089 A5 JP2024541089 A5 JP 2024541089A5 JP 2024529509 A JP2024529509 A JP 2024529509A JP 2024529509 A JP2024529509 A JP 2024529509A JP 2024541089 A5 JP2024541089 A5 JP 2024541089A5
- Authority
- JP
- Japan
- Prior art keywords
- scn11a
- variant
- nucleic acid
- acid molecule
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163281640P | 2021-11-20 | 2021-11-20 | |
| US63/281,640 | 2021-11-20 | ||
| PCT/US2022/080208 WO2023092112A1 (en) | 2021-11-20 | 2022-11-21 | Methods of treating headaches and migraines with sodium voltage-gated channel alpha subunit 11 (scn11a) inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024541089A JP2024541089A (ja) | 2024-11-06 |
| JP2024541089A5 true JP2024541089A5 (cg-RX-API-DMAC7.html) | 2025-11-20 |
Family
ID=84829809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529509A Pending JP2024541089A (ja) | 2021-11-20 | 2022-11-21 | ナトリウム電位依存性チャネルαサブユニット１１（ＳＣＮ１１Ａ）阻害剤による頭痛及び片頭痛の治療方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230279400A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4433090A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024541089A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240109247A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118234513A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022393586A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3237033A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL312312A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024006042A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023092112A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025037925A1 (ko) | 2023-08-16 | 2025-02-20 | 주식회사 엘지에너지솔루션 | 이차전지용 양극 및 이를 포함하는 이차전지 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US96183A (en) * | 1869-10-26 | Improved ciiothes-mne supporter | ||
| EP2769724A1 (en) * | 2013-02-22 | 2014-08-27 | Université d'Aix-Marseille | Inhibitors of Na(v) 1.9 channel activity and uses thereof for treating pain |
| US9139648B1 (en) * | 2014-07-15 | 2015-09-22 | Kymab Limited | Precision medicine by targeting human NAV1.9 variants for treatment of pain |
| JP6782412B2 (ja) * | 2014-11-25 | 2020-11-11 | 国立大学法人京都大学 | 疼痛遺伝子及びその用途 |
| CN108530534B (zh) * | 2017-03-03 | 2021-06-18 | 易森荟(武汉)生物医药有限公司 | Nav1.9的靶点多肽、与其结合的抗体及抗体片段和相关药物组合物 |
-
2022
- 2022-11-21 US US18/057,298 patent/US20230279400A1/en active Pending
- 2022-11-21 KR KR1020247015157A patent/KR20240109247A/ko active Pending
- 2022-11-21 WO PCT/US2022/080208 patent/WO2023092112A1/en not_active Ceased
- 2022-11-21 JP JP2024529509A patent/JP2024541089A/ja active Pending
- 2022-11-21 AU AU2022393586A patent/AU2022393586A1/en active Pending
- 2022-11-21 CN CN202280074256.XA patent/CN118234513A/zh active Pending
- 2022-11-21 IL IL312312A patent/IL312312A/en unknown
- 2022-11-21 CA CA3237033A patent/CA3237033A1/en active Pending
- 2022-11-21 EP EP22839091.0A patent/EP4433090A1/en active Pending
- 2022-11-21 MX MX2024006042A patent/MX2024006042A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pariollaud et al. | Circadian clock component REV-ERBα controls homeostatic regulation of pulmonary inflammation | |
| Liu et al. | Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice | |
| Hou et al. | Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways | |
| Chandel et al. | Role of oxidants in NF-κB activation and TNF-α gene transcription induced by hypoxia and endotoxin | |
| Skendros et al. | Regulated in development and DNA damage responses 1 (REDD1) links stress with IL-1β–mediated familial Mediterranean fever attack through autophagy-driven neutrophil extracellular traps | |
| Pereira et al. | Rosiglitazone and 15-deoxy-Δ12, 14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms | |
| Wehbi et al. | Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors | |
| Zhao et al. | Down-regulation of nuclear HMGB1 reduces ischemia-induced HMGB1 translocation and release and protects against liver ischemia-reperfusion injury | |
| Sumida et al. | Complement C1q-induced activation of β-catenin signalling causes hypertensive arterial remodelling | |
| Tipsmark et al. | Salinity regulates claudin mRNA and protein expression in the teleost gill | |
| Terenzi et al. | Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium | |
| Gong et al. | Paired related homeobox protein 1 regulates PDGF-induced chemotaxis of hepatic stellate cells in liver fibrosis | |
| Yokota et al. | STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model | |
| Liu et al. | PTK7 regulates Id1 expression in CD44-high glioma cells | |
| Guo et al. | Transient receptor potential Vanilloid 1-based gene therapy alleviates orthodontic pain in rats | |
| WO2008011603A2 (en) | Modulating notch1 signaling pathway for treating neuroendocrine tumors | |
| Zhao et al. | Disturbing NLRP3 acetylation and inflammasome assembly inhibits androgen receptor‐promoted inflammatory responses and prostate cancer progression | |
| Siddiqi et al. | CXCR4 promotes renal tubular cell survival in male diabetic rats: implications for ligand inactivation in the human kidney | |
| Fang et al. | Molecular basis of Cav2. 3 calcium channels in rat nociceptive neurons | |
| Zhou et al. | Disruption of CXCR3 function impedes the development of Sjögren’s syndrome-like xerostomia in non-obese diabetic mice | |
| Suzuki et al. | Tissue accumulation of neutrophil extracellular traps mediates muscle hyperalgesia in a mouse model | |
| Chen et al. | Protective effect of RNase on unilateral nephrectomy-induced postoperative cognitive dysfunction in aged mice | |
| Nakamura et al. | HIF-1α and MIF enhance neutrophil-driven type 3 immunity and chondrogenesis in a murine spondyloarthritis model | |
| JP2024541089A5 (cg-RX-API-DMAC7.html) | ||
| JP2026053561A (ja) | 循環からミトコンドリアｄｎａ又はゲノムｄｎａを枯渇させることにより疾患及び症状を治療する組成物及び方法 |